Bulgaria vs Greece: Cause of death, by non-communicable diseases, ages 60+, male
Bulgaria
76.8%
in 2021
Greece
76.5%
in 2021
Bulgaria rank
62nd
Greece rank
64th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Bulgaria
- Greece
How they compare
Bulgaria currently reports 76.8% against 76.5% in Greece, a difference of 0.3%.
Across all 6 years both countries report, Bulgaria has been ahead every year.
Bulgaria ranks 62nd and Greece ranks 64th of 185 countries.
Bulgaria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bulgaria | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.9% | 94.0% | 0.9% | Bulgaria |
| 2010s | 96.3% | 89.8% | 6.5% | Bulgaria |
| 2020s | 82.2% | 80.3% | 1.8% | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Bulgaria or Greece?
- Bulgaria, at 76.8% against 76.5% in Greece as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Bulgaria and Greece?
- 0.3%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Greece?
- 6 years are reported by both, from 2000 to 2021.
- How do Bulgaria and Greece rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Bulgaria ranks 62nd and Greece ranks 64th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.